this closely corresponds to the reversal by insulin therapy of the postreceptor defect expressed in vivo and provides further evidence that a cellular cause of the postreceptor defect in type ii diabetes is a decrease in glucose transport system activity in the major insulin target tissues .
C0011860
type ii diabetes
C0021641
insulin